Filtros de búsqueda

Lista de obras de Ana Belén Pérez

Baseline resistance-guided therapy does not enhance the response to interferon-free treatment of HCV infection in real life

artículo científico publicado en 2018

Continued propagation of the CRF19_cpx variant among HIV-positive MSM patients in Spain.

artículo científico publicado en 2018

Efficacy and safety of the combination of reduced duration prophylaxis followed by immuno-guided prophylaxis to prevent cytomegalovirus disease in lung transplant recipients (CYTOCOR STUDY): an open-label, randomised, non-inferiority clinical trial

scientific article published on 15 August 2019

Hepatitis C virus core antigen in the management of patients treated with new direct-acting antivirals

artículo científico publicado en 2017

Increasing importance of European lineages in seeding the hepatitis C virus subtype 1a epidemic in Spain

article

Paritaprevir/ritonavir/ombitasvir plus dasabuvir in HIV/HCV-coinfected patients with genotype 1 in real-life practice

artículo científico publicado en 2018

Prevalence of NS5A Resistance Associated Substitutions in patients with hepatitis C virus genotypes 1a and 3: Impact on Current Therapeutic Strategies

artículo científico publicado en 2018

Prevalence of resistance associated substitutions and efficacy of baseline resistance-guided chronic hepatitis C treatment in Spain from the GEHEP-004 cohort

scientific article published on 30 August 2019

Relapse or reinfection after failing hepatitis C direct acting antiviral treatment: Unravelled by phylogenetic analysis

artículo científico publicado en 2018

Resistance to direct antiviral agents for hepatitis C virus infection. Impact on clinical practice?

artículo científico publicado en 2016

The cobas® HCV GT is a new tool that accurately identifies Hepatitis C virus genotypes for clinical practice

artículo científico publicado en 2017

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda